Qiagen Terminates Thermo Fisher Deal After Shareholders Reject Last Offer

Qiagen's shareholders said Thermo Fisher's final offer price for the diagnostics company was too low.

pathdoc/Shutterstock.com

Qiagen NV has terminated its agreement to be acquired by Thermo Fisher Scientific after shareholders rejected an amended offer price.

On 16 July, Thermo Fisher Scientific and Qiagen announced an amendment to the original $11.5bn buyout announced in March. Thermo...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Deals

More from Business